[
    [
        {
            "time": "2018-01-02",
            "original_text": "Pharmaceutical Stocks With Big Moats and Bridges",
            "features": {
                "keywords": [
                    "pharmaceutical",
                    "stocks",
                    "moats",
                    "bridges"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pharmaceutical Stocks With Big Moats and Bridges",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-01-03",
            "original_text": "Lilly Announces Webcast to Discuss ADA Presentations and Diabetes Portfolio",
            "features": {
                "keywords": [
                    "Lilly",
                    "webcast",
                    "ADA",
                    "diabetes",
                    "portfolio"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly Announces Webcast to Discuss ADA Presentations and Diabetes Portfolio",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-01-04",
            "original_text": "Lilly In-Licenses Private Biotech's Non-Opoid Pain Candidate",
            "features": {
                "keywords": [
                    "Lilly",
                    "in-licenses",
                    "biotech",
                    "non-opoid",
                    "pain"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly In-Licenses Private Biotech's Non-Opoid Pain Candidate",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2018-01-05",
            "original_text": "3 Big Stock Charts for Wednesday: Juniper Networks, Eli Lilly and Hormel Foods",
            "features": {
                "keywords": [
                    "stock",
                    "charts",
                    "Juniper Networks",
                    "Eli Lilly",
                    "Hormel Foods"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology",
                    "healthcare",
                    "consumer goods"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "3 Big Stock Charts for Wednesday: Juniper Networks, Eli Lilly and Hormel Foods",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-01-06",
            "original_text": "Pro-choice groups lost in Alabama despite outspending the pro-life side by 100-to-1",
            "features": {
                "keywords": [
                    "pro-choice",
                    "Alabama",
                    "outspending",
                    "pro-life"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Pro-choice groups lost in Alabama despite outspending the pro-life side by 100-to-1",
                "Correlation": 2,
                "Sentiment": 4,
                "Importance": 3,
                "Impact": 2,
                "Duration": 2,
                "Entity_Density": 1,
                "Market_Scope": 2,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-07",
            "original_text": "Bayer to work with Foundation Medicine on selecting cancer patients",
            "features": {
                "keywords": [
                    "Bayer",
                    "Foundation Medicine",
                    "cancer",
                    "patients"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Bayer to work with Foundation Medicine on selecting cancer patients",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]